Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective Study
Massimiliano Berretta(University of Messina), Liliana Montella(Ospedale Santa Maria), Alessia Bignucolo(University of Messina), Gianluca Vanni(Policlinico Tor Vergata), Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Raffaele Di Francia(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Oreste Claudio Buonomo(University of Basilicata), Mariachiara Santorsola(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giuliana Ciappina(University of Ferrara), Gaetano Facchini(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Alessandro Ottaiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Giordana Di Mauro(University of Messina), Monica Montopoli(University of Padua), Tindara Franchina(University of Messina), Enrica Toscano(University of Messina), Patrizia Carroccio(University of Messina), Paola Muscolino(University of Messina), Claudia Gelsomino(University of Messina), Antonio Picone(University of Messina)
Cited by 5
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
FGFR a promising druggable target in cancer: Molecular biology and new drugs
|Critical Reviews in Oncology/Hematology|2017|203
Epithelial-mesenchymal transition in prostate cancer: an overview
|Oncotarget|2017|177
Metabolic Plasticity in Chemotherapy Resistance
|Frontiers in Oncology|2020|175
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116